Clearline Capital LP Standard Biotools Inc. Transaction History

Clearline Capital LP

  • $2.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$3.94 - $7.09 $916,424 - $1.65 Million
-232,595 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$5.45 - $8.65 $404,575 - $642,124
-74,234 Reduced 24.19%
232,595 $1.4 Million
Q3 2020

Nov 16, 2020
BUY
$4.34 - $11.43 $1.33 Million - $3.51 Million
306,829 New
306,829 $2.28 Million

Others Institutions Holding LAB

# of Institutions
143
Shares Held
279M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $130M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email